Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1172/jci10259 | Inhibition of VEGF receptors causes lung cell apoptosis and emphysema |
| https://doi.org/10.1161/circresaha.109.197491 | Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 Pathway |
| https://doi.org/10.1161/01.cir.0000099502.17776.c2 | Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension |
| https://doi.org/10.1677/erc.1.00829 | Malignant pheochromocytoma: current status and initiatives for future progress |
| https://doi.org/10.1056/nejmoa2211644 | Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B |
| https://doi.org/10.1056/nejmoa035115 | Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension |
| https://doi.org/10.1183/09031936.00090608 | Pulmonary veno-occlusive disease |
| https://doi.org/10.1183/09031936.00169113 | Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature |
| https://doi.org/10.1097/01.ccm.0000120052.77953.07 | Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure* |
| https://doi.org/10.1164/rccm.201403-0446oc | Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia |
| https://doi.org/10.1253/circj.cj-66-0158 | Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017) |
| https://doi.org/10.1097/00041433-200104000-00007 | Genetic basis of sitosterolemia |
| https://doi.org/10.1172/jci38079 | Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway |
| https://doi.org/10.1016/j.rmed.2010.05.009 | Categorization and impact of pulmonary hypertension in patients with advanced COPD |
| https://doi.org/10.1159/000322475 | Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension |
| https://doi.org/10.1196/annals.1353.001 | An Overview of Pheochromocytoma |
| https://doi.org/10.1183/09059180.00005713 | Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives |
| https://doi.org/10.1136/thoraxjnl-2017-210764 | British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations |
| https://doi.org/10.1183/09031936.06.00015206 | Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review |
| https://doi.org/10.3899/jrheum.080447 | Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma |
| https://doi.org/10.1183/13993003.01919-2018 | The importance of patient perspectives in pulmonary hypertension |
| https://doi.org/10.4161/jkst.22366 | STAT3 signaling in pulmonary arterial hypertension |
| https://doi.org/10.1055/s-0028-1128139 | The Protean Manifestations of Pheochromocytoma |
| https://doi.org/10.1136/annrheumdis-2019-216476 | Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension |
| https://doi.org/10.1183/09031936.00016806 | Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study |
| Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension - Seven sites, United States, 2003-2006 | |
| https://doi.org/10.1164/rccm.201701-0150ws | Enhancing Insights into Pulmonary Vascular Disease Through a Precision Medicine Approach. A Joint NHLBI–Cardiovascular Medical Research and Education Fund Workshop Report |
| https://doi.org/10.1016/j.ijcard.2014.09.024 | Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions |
| https://doi.org/10.1177/2045894020922799 | Could pulmonary arterial hypertension patients be at a lower risk from severe COVID‐19? |
| https://doi.org/10.1002/pul2.12127 | Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension |
| https://doi.org/10.1177/2045894018775056 | Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups |
| https://doi.org/10.1164/rccm.202109-2079pp | Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension? |
| https://doi.org/10.1177/2045893217710639 | Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges |
| https://doi.org/10.1016/j.vph.2021.106882 | Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis |
| https://doi.org/10.1183/13993003.02608-2020 | In vivodemonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography |
| https://doi.org/10.1002/pul2.12063 | BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension |
| https://doi.org/10.1164/rccm.202203-0485oc | First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease |
| https://doi.org/10.1016/j.hfc.2022.08.015 | Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension |
| https://doi.org/10.1183/13993003.01129-2024 | Exploring the patient perspective in pulmonary hypertension |
| https://doi.org/10.1097/ms9.0000000000001498 | MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeutics |
| https://doi.org/10.1002/ejhf.3236 | A Roadmap for Therapeutic Discovery in Pulmonary Hypertension Associated with Left Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function |
| https://doi.org/10.1161/jaha.124.036730 | Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort |
| https://doi.org/10.1016/j.chpulm.2024.100046 | Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort |
| https://doi.org/10.1111/nicc.13060 | Intensive care nurses' perceptions and awareness of delirium and delirium prevention guidelines |
| https://doi.org/10.1097/rlu.0000000000005142 | Diagnostic Performance of Perfusion-Only SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension in Comparison With Ventilation-Perfusion Planar, SPECT, and SPECT/CT Imaging |
| https://doi.org/10.1513/annalsats.202206-474rl | Progression of Pulmonary Fibrosis According to Radiological Pattern in Asbestosis |
| https://doi.org/10.1182/blood.2024025322 | Structure and interactions of the proteins from the contact system |
| https://doi.org/10.1172/jci5911 | Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension |
| https://doi.org/10.1111/j.1524-6175.2002.01452.x | Pheochromocytoma |
| https://doi.org/10.1097/aln.0b013e318167aee2 | Cardiac Arrests and Deaths Associated with Malignant Hyperthermia in North America from 1987 to 2006 |
| https://doi.org/10.1183/09031936.00017809 | Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease |
| https://doi.org/10.1152/physiolgenomics.00081.2001 | Hypoxia induces different genes in the lungs of rats compared with mice |
| https://doi.org/10.1164/rccm.201311-1954st | An Official American Thoracic Society Statement: Pulmonary Hypertension Phenotypes |
| https://doi.org/10.1016/j.rmed.2006.04.014 | NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension |
| https://doi.org/10.1136/heartjnl-2017-311650 | Infective endocarditis in adults with congenital heart disease remains a lethal disease |
| https://doi.org/10.1513/annalsats.201512-806oc | Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience |
| https://doi.org/10.1152/ajplung.00111.2005 | Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth |
| https://doi.org/10.1136/thoraxjnl-2017-211440 | Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension |
| https://doi.org/10.1093/sw/56.3.201 | Social Work Interest in Prevention: A Content Analysis of the Professional Literature |
| https://doi.org/10.1183/13993003.00414-2020 | EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR |
| https://doi.org/10.1093/annonc/mdq316 | Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity |
| https://doi.org/10.2147/vhrm.s4713 | Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient |
| https://doi.org/10.1007/s00408-019-00234-3 | Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability |
| https://doi.org/10.1136/bmjresp-2016-000174 | Post-tuberculous fibrosing mediastinitis: a review of the literature |
| https://doi.org/10.1164/rccm.202112-2761oc | COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study |
| https://doi.org/10.1016/j.berh.2021.101695 | Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS) |
| https://doi.org/10.1016/j.chest.2019.02.402 | Extended Anticoagulation for VTE |
| https://doi.org/10.1002/ejhf.1067 | Haemodynamic Effects of an Acute Vasodilator Challenge in Heart Failure Patients with Reduced Ejection Fraction and Different forms of Post-Capillary Pulmonary Hypertension |
| https://doi.org/10.1016/j.jvir.2016.03.035 | Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel |
| https://doi.org/10.21693/1933-088x-16.4.185 | The Pulmonary Hypertension Association Registry: Rationale, Design, and Role in Quality Improvement |
| https://doi.org/10.1097/00004872-200312000-00019 | Protective effects of dietary potassium chloride on hemodynamics of Dahl salt-sensitive rats in response to chronic administration of sodium chloride |
| https://doi.org/10.1177/2045894018788268 | Non‐invasive right ventricular load adaptability indices in patients with scleroderma‐associated pulmonary arterial hypertension |
| https://doi.org/10.1159/000452957 | Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link? |
| https://doi.org/10.1177/2045893217741429 | Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension |
| https://doi.org/10.5603/cj.a2016.0044 | Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension |
| https://doi.org/10.14814/phy2.14322 | Echocardiographic evaluations of right ventriculo–arterial coupling in experimental and clinical pulmonary hypertension |
| https://doi.org/10.1177/20458940211020913 | Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry |
| https://doi.org/10.1161/circulationaha.121.058635 | Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| https://doi.org/10.1161/circulationaha.112.118547 | Validation of the 6-Minute Walk in Patients With Pulmonary Arterial Hypertension |
| https://doi.org/10.1164/rccm.201710-2093pp | Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report |
| https://doi.org/10.1177/2045893217716107 | Left main coronary artery compression by a dilated main pulmonary artery and left coronary sinus of Valsalva aneurysm in a patient with heritable pulmonary arterial hypertension and FLNA mutation |
| https://doi.org/10.1002/ejhf.2830 | European Society of Cardiology Quality Indicators for the Care and Outcomes of Adults with Pulmonary Arterial Hypertension. Developed in Collaboration with the Heart Failure Association of the European Society of Cardiology |
| https://doi.org/10.37765/ajmc.2021.88611 | Reducing economic burden and improving quality of life in pulmonary arterial hypertension |
| https://doi.org/10.1161/circulationaha.123.067590 | Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study |
| https://doi.org/10.1111/dom.14915 | Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants ( |
| https://doi.org/10.1097/00001503-199902000-00007 | Nitric oxide and almitrine: the definitive answer for hypoxemia |
| https://doi.org/10.1097/cm9.0000000000000145 | Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease |
| https://doi.org/10.1002/pul2.12178 | Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension |
| https://doi.org/10.1016/j.cpcardiol.2022.101309 | Shock Index, Modified Shock Index, and Age-adjusted Shock Index as Predictors of In-hospital Death in Acute Heart Failure. Sub Analysis of the ARGEN IC |
| https://doi.org/10.37765/ajmc.2021.88610 | The evolving treatment landscape of pulmonary arterial hypertension |
| https://doi.org/10.1136/heartjnl-2023-322742 | Restoration of right ventricular function in the treatment of pulmonary arterial hypertension |
| https://doi.org/10.1111/hae.14985 | Administration of gene therapy for haemophilia – The hub and spoke model and its regional differences and challenges |
| https://doi.org/10.1183/23120541.00027-2023 | Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases |
| https://doi.org/10.1093/cvr/cvaf028 | Bone morphogenetic protein 10 is increased in pre-capillary pulmonary hypertension patients |
| https://doi.org/10.4266/acc.2016.01032 | Central extracorporeal membrane oxygenation and early rehabilitation for persistent severe pulmonary hypertension following pulmonary endarterectomy |
| https://doi.org/10.1093/ehjacc/zuaf141 | Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team |
| https://doi.org/10.1183/23120541.00297-2025 | The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients |
| https://doi.org/10.1002/pul2.70130 | Pulmonary Hypertension Global Patient Survey: A Call to Action 2025 |
| https://doi.org/10.5837/bjc.2021.032 | Real-world experience of selexipag titration in pulmonary arterial hypertension |
| https://doi.org/10.1152/ajplung.00196.2024 | Deep phenotyping of pulmonary edema and pulmonary vascular permeability in COVID-19 ARDS |